HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities research analysts at HC Wainwright increased their Q2 2027 earnings estimates for HIVE Blockchain Technologies in a report issued on Monday, August 17th. HC Wainwright analyst M. Colonnese now anticipates that the company will earn ($0.22) per share for the quarter, up from their prior estimate of ($0.25). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q3 2027 earnings at ($0.13) EPS, Q4 2027 earnings at ($0.08) EPS and FY2028 earnings at ($0.32) EPS.
Separately, Chardan Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- Amazon Plugs $18B Into the Southern Power Grid
- Speed Sells: Cerebras Cracks the Silicon Ceiling
- Amid Legal Risks, This Company Is Still Rated a Buy
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
